Condition

Arrhythmia, Cardiac

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting0

Common interventions4

Lead sponsors shown4

Clinical trials

4 shown

Evaluation of the LVivo Image Quality Scoring (IQS)NCT05563701 · 2022-09-05

COMPLETED

Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac PatientsNCT03647891 · 2017-07-01

WITHDRAWN

Hypoglycaemia and Cardiac Arrhythmias in Type 2 DiabetesNCT03150030 · 2017-02-01

COMPLETED

Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）NCT06884436 · 2015-01-01

COMPLETED

Common interventions

Combined hyper- and hypoglycaemic clampOTHER1 Continuous glucose monitoring (iPro2, Medtronic, Minneapolis, MN, USA)DEVICE1 Continuous Positive Airway PressureDEVICE1 Loop recorder (Reveal LINQ, Medtronic, Minneapolis, MN, USA)DEVICE1

Leading sponsors

Chinese PLA General Hospital1 DiA Imaging Analysis Ltd1 Kaiser Permanente1 University Hospital, Gentofte, Copenhagen1

Trial status mix

COMPLETED3

WITHDRAWN1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.